Clinical Trial Update: Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing SR-8541A in combination with Botensilimab and Balstilimab for refractory metastatic microsatellite-stable colorectal cancer; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)
• SR-8541A (SR-8541A)

Snippet

Sponsor: Stingray Therapeutics | Conditions: Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | Phase 2 | Status: RECRUITING